1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Moxetumomab pasudotox and minimal residual disease in hairy cell leukemia
    Meeting Abstract

    Kreitman, R. J.; Arons, E.; Still, K.; Tallman, M. S.; Stetler-Stevenson, M.; Yuan, C.; FitzGerald, D. J. P.; Pastan, I.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final overall survival analysis for the RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC (mRCC)
    Meeting Abstract

    Knox, J. J.; Barrios, C. H.; Kim, T. M.; Cosgriff, T.; Srimuninnimit, V.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST)
    Meeting Abstract

    Kieran, M. W.; Hargrave, D. R.; Cohen, K. J.; Aerts, I.; Dunkel, I. J.; Hummel, T. R.; Jimenez, I.; Pearson, A. D. J.; Pratilas, C. A.; Whitlock, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Elevated blood pressure (BP) and adverse events (AEs) of hypertension (HTN) in ponatinib (PON) leukemia trials
    Meeting Abstract

    Khoury, H. J.; Baccarani, M.; Guilhot, F.; Hochhaus, A.; Hughes, T. P.; Lipton, J. H.; Lustgarten, S.; Yanase, K.; Conlan, M. G.; Cortes, J. E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC)
    Meeting Abstract

    Khasraw, M.; Mukaro, V. R.; West, L.; Brandt, C.; Woollett, A. M.; Edwards, M.; Spokes, R.; Mitchell, G.; Prince, K.; Hayes, T. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Improvement in long-term survival in patients with metastatic colorectal cancer (CRC) after liver resection with modern chemotherapy and hepatic arterial infusion (HAI)
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Boucher, T. M.; Capanu, M.; DeMatteo, R. P.; Jarnagin, W. R.; Kingham, T. P.; Allen, P. J.; Fong, Y.; Cercek, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab (MSB0010718C) in patients with metastatic Merkel cell carcinoma
    Meeting Abstract

    Kaufman, H.; Hamid, O.; D'Angelo, S. P.; Yuan, G. J.; Chin, K. M.; Bhatia, S.; Cuillerot, J. M.; Nghiem, P.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Sarcoma: A Lynch syndrome (LS)-associated malignancy?
    Meeting Abstract

    Kaczmar, J. M.; Everett, J.; Ruth, K.; Stoffel, E. M.; Stoll, J.; Kupfer, S.; Hampel, H.; Stadler, Z. K.; Gaddam, P.; Rybak, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of alpha-particle therapy with actinium-225 ((225)Ac)-lintuzumab (anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Douer, D.; Levy, M. Y.; Estey, E.; Kantarjian, H. M.; Earle, D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save